Official Title
Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection
Brief Summary

Patients who meet inclusion criteria will be randomized into treatment vs control group. Treatment groups will undergo Hyperbaric Oxygen Therapy (HBOT) and compared to the control group.

Detailed Description

After enrollment, patients will be randomized into treatment vs control group. Both populations will receive the same inpatient medical treatment. All patients in the treatment group will undergo hyperbaric oxygen therapy under the same treatment protocol. After completion of the treatment protocol, specific study endpoints will be compared between the treatment and control groups.

Not yet recruiting
COVID-19

Device: Hyperbaric Oxygen Therapy
Hyperbaric Oxygen Therapy delivered at a specific uniformed pressure and duration.
HBOT treatment group

Eligibility Criteria

Inclusion Criteria:

- Adult inpatients >18 years old

- Positive PCR COVID-19 testing

- CT evidence of interstitial opacity

- Oxygen saturation

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years
Countries
United States
Locations

Ochsner Medical Center
New Orleans, Louisiana, 70121

Contacts

John F Engle, MD
985-768-8918
englemd94@gmail.com

Michael D Lindley, MD
504-957-3326
mdlindley@gmail.com

Jeffery S Kuo, MD
Study Chair
Ochsner Health System

Ochsner Health System
NCT Number
Keywords
Covid-19
MeSH Terms
Infection